000026861 000__ 01316cam\a2200421\i\4500 000026861 001__ 26861 000026861 003__ SzGeWIPO 000026861 005__ 20240708162307.0 000026861 008__ 071015s2012 enk|||||r|||| 00| 0 eng d 000026861 035__ $$a(wipo)0 000026861 035__ $$a(OCoLC)1161775710 000026861 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL 000026861 041__ $$aeng 000026861 043__ $$ae------ 000026861 050_4 $$aK5$$b.U72 000026861 08204 $$a346.4048$$220 000026861 084__ $$aGB 10 000026861 1001_ $$aMinssen, T.,$$eauthor. 000026861 24514 $$aThe Industrial Application Requirement for Biotech Inventions in Light of Recent EPO and UK Case Law :$$bA Plausible Approach or a Mere "Hunting Licence"? /$$cMinssen, T., Nilsson, D. 000026861 264_1 $$aLondon, England :$$bSweet & Maxwell,$$c2012. 000026861 300__ $$a1 volume ([15] pages) ;$$c[28] cm. 000026861 336__ $$atext$$btxt$$2rdacontent 000026861 337__ $$aunmediated$$bn$$2rdamedia 000026861 338__ $$avolume$$bnc$$2rdacarrier 000026861 4901_ $$aEuropean Intellectual Property Review (EIPR),$$x0142-0461 ;$$v2012, Vol. 34, No. 10, pages 689-703 000026861 650_0 $$aIntellectual property$$zEurope. 000026861 650_4 $$aIndustrial application 000026861 650_4 $$aEuropean Patent Office (EPO) 000026861 650_4 $$aBiotechnology$$zEuropean Community (EU)$$yInventions 000026861 651_0 $$aEurope$$xCommerce$$xLaw and legislation. 000026861 7001_ $$aNilsson, D. 000026861 830_0 $$aEuropean Intellectual Property Review (EIPR) ;$$v2012, Vol. 34, No. 10, pages 689-703. 000026861 903__ $$aEuropean Intellectual Property Review (EIPR). 000026861 904__ $$aJournal article 000026861 942__ $$cART$$jGB 10 2012 Vol 34 No 10$$2ddc 000026861 952__ $$w2012-10-19$$p2012-0268$$u41343$$bMAIN$$10$$kGB 10$$v2012-10-19$$70$$cMain library$$yART 000026861 980__ $$aBIB 000026861 999__ $$c29262$$d29262